Current antimicrobial management of community-acquired pneumonia in HIV-infected children

References

• Theodoratou E, McAllister DA, Reed C, et al. Global, regional, and national estimates of pneumonia burden in HIV-infected children in 2010: a meta-analysis and modelling study. Lancet Infect Dis. 2014;14(12):1250–1258.
   PubMed Web of Science ®Google Scholar
• Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data 2017 2017; [cited 2018 Aug 4]. Available from: http://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf
   Google Scholar
• World Health Organisation. Global health observatory (GHO) prevention of mother-to-child transmission (PMTCT) 2018. [cited 2018 Aug 4]. Available from: http://www.who.int/gho/hiv/epidemic_response/PMTCT_text/en/
   Google Scholar
• World Health Organisation. Tuberculosis and respiratory infections unit. Case management of acute respiratory infections in children in developing countries: report of a working group meeting, Geneva, 1984 Apr 3–6, 2nd revision. Geneva: World Health Organisation; 1985.
   Google Scholar
• Lambrechts T, Bryce J, Orinda V. Integrated management of childhood illness: a summary of first experiences. Bull World Health Organ. 1999;77(7):582–594. PubMed PMID: 10444882; PubMed Central PMCID: PMCPMC2557705. eng.
   PubMed Web of Science ®Google Scholar
• McNally LM, Jeena PM, Gajee K, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet. 2007 Apr 28;369(9571):1440–1451. PubMed PMID: 17467514; eng.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Integrated management of childhood illness (IMCI). WHO recommendations on the management of diarrhoea and pneumonia in HIV-infected infants and children. Geneva: World Health Organisation; 2010.
   Google Scholar
• Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Department of Health and Human Services. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children. 2018. https://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf
   Google Scholar
• Zar HJ, Jeena P, Argent A, et al. Diagnosis and management of community-acquired pneumonia in childhood–South African thoracic society guidelines. S Afr Med J. 2005 Dec;95(12 Pt 2):977–81, 984–90. PubMed PMID: 16482985; eng.
   Web of Science ®Google Scholar
• Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis. 1986 Mar–Apr;5(2):247–252. PubMed PMID: 3952013; eng.
   PubMedGoogle Scholar
• Madhi SA, Petersen K, Madhi A, et al. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis. 2000 Jul;31(1):170–176. . PubMed PMID: 10913417; eng.
   PubMed Web of Science ®Google Scholar
• Calder D, Qazi S. Evidence behind the WHO guidelines: hospital care for children: what is the aetiology of pneumonia in HIV-infected children in developing countries? J Trop Pediatr. 2009;55(4):219–224.
   PubMed Web of Science ®Google Scholar
• Zar HJ, Apolles P, Argent A, et al. The etiology and outcome of pneumonia in human immunodeficiency virus-infected children admitted to intensive care in a developing country. Pediatr Crit Care Med. 2001 Apr;2(2):108–112. PubMed PMID: 12797868; eng.
   PubMedGoogle Scholar
• Zar HJ, Hanslo D, Tannenbaum E, et al. Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatr. 2001 Feb;90(2):119–125. PubMed PMID: 11236037; eng.
   PubMed Web of Science ®Google Scholar
• Graham SM, Coulter JB, Gilks CF. Pulmonary disease in HIV-infected African children. Int J Tuberculosis Lung Dis. 2001 Jan;5(1):12–23. PubMed PMID: 11263511; eng.
   PubMed Web of Science ®Google Scholar
• Dankner WM, Lindsey JC, Levin MJ. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Pediatr Infect Dis J. 2001 Jan;20(1):40–48. PubMed PMID: 11176565; eng.
   PubMed Web of Science ®Google Scholar
• Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet. 2002;360(9338):985–990.
   PubMed Web of Science ®Google Scholar
• Graham SM, Molyneux EM, Walsh AL, et al. Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr Infect Dis J. 2000 Dec;19(12):1189–1196. PubMed PMID: 11144383; eng.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Petersen K, Khoosal M, et al. Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. Pediatr Infect Dis J. 2002 Apr;21(4):315–321. PubMed PMID: 12075763; eng.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Kuwanda L, Cutland C, et al. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis. 2005 May 15;40(10):1511–1518. . PubMed PMID: 15844075; eng.
   PubMed Web of Science ®Google Scholar
• Bliss SJ, O’Brien KL, Janoff EN, et al. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis. 2007;8:67–80.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Petersen K, Madhi A, et al. Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Pediatr Infect Dis J. 2000 Dec;19(12):1141–1147. PubMed PMID: 11144373; eng.
   PubMed Web of Science ®Google Scholar
• Cohen C, von Mollendorf C, de Gouveia L, et al. Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in South Africa: a matched case-control study. Clin Infect Dis. 2014 Sep 15;59(6):808–818. . PubMed PMID: 24917657; PubMed Central PMCID: PMCPMC4144265.
   PubMed Web of Science ®Google Scholar
• von Mollendorf C, Tempia S, von Gottberg A, et al. Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa. PubMed PMID: 28671978; PubMed Central PMCID: PMCPMC5495214 PLoS One. 2017;12(7):e0179905.
   PubMed Web of Science ®Google Scholar
• Cotton MF, Wasserman E, Smit J, et al. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa. BMC Infect Dis. 2008 Apr 1;8:40. PubMed PMID: 18380900; PubMed Central PMCID: PMCPMC2329621. eng.
   PubMed Web of Science ®Google Scholar
• Mulu W, Yizengaw E, Alemu M, et al. Pharyngeal colonization and drug resistance profiles of Morraxella catarrrhalis, Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae among HIV infected children attending ART clinic of Felegehiwot referral hospital, Ethiopia. PLoS One. 2018;13(5):e0196722. PubMed PMID: 29746496; PubMed Central PMCID: PMCPMC5944927. eng.
   PubMed Web of Science ®Google Scholar
• Crichton H, O’Connell N, Rabie H, et al. Neonatal and paediatric bloodstream infections: pathogens, antimicrobial resistance patterns and prescribing practice at Khayelitsha District Hospital, Cape Town, South Africa. South Afr Med J. 2018;108:2.
   PubMed Web of Science ®Google Scholar
• Hesseling AC, Cotton MF, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis. 2009 Jan 1;48(1):108–114. PubMed PMID: 19049436.
   PubMed Web of Science ®Google Scholar
• Jeena PM, Pillay P, Pillay T, et al. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. Int J Tuberculosis Lung Dis. 2002 Aug;6(8):672–678. PubMed PMID: 12150478; eng.
   PubMed Web of Science ®Google Scholar
• Coovadia HM, Jeena P, Wilkinson D. Childhood human immunodeficiency virus and tuberculosis co-infections: reconciling conflicting data. Int J Tuberculosis Lung Dis. 1998 Oct;2(10):844–851. PubMed PMID: 9783533; eng.
   PubMed Web of Science ®Google Scholar
• Schaaf HS, Marais BJ, Whitelaw A, et al. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis. 2007 Nov 29;7:140. PubMed PMID: 18047651; PubMed Central PMCID: PMCPMC2225409.
   PubMed Web of Science ®Google Scholar
• Hesseling AC, Kim S, Madhi S, et al. High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial. Int J Tuberculosis Lung Dis. 2012 Feb;16(2):192–195. PubMed PMID: 22236919; PubMed Central PMCID: PMCPMC3265022.
   PubMed Web of Science ®Google Scholar
• Walters E, Cotton MF, Rabie H, et al. Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy. BMC Pediatr. 2008 Jan 11;8:1. PubMed PMID: 18186944; PubMed Central PMCID: PMCPMC2246130.
   PubMed Web of Science ®Google Scholar
• Zampoli M, Kilborn T, Eley B. Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children. Int J Tuberculosis Lung Dis. 2007 Apr;11(4):417–423. PubMed PMID: 17394688; eng.
   PubMed Web of Science ®Google Scholar
• Martinson NA, Moultrie H, van Niekerk R, et al. HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort. Int J Tuberculosis Lung Dis. 2009 Jul;13(7):862–867. PubMed PMID: 19555536; eng.
   PubMed Web of Science ®Google Scholar
• Simonds RJ, Oxtoby MJ, Caldwell MB, et al. Pneumocystis carinii pneumonia among US children with perinatally acquired HIV infection. Jama. 1993 Jul 28;270(4):470–473. PubMed PMID: 8320786; eng.
   PubMed Web of Science ®Google Scholar
• Williams AJ, Duong T, McNally LM, et al. Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection. Aids. 2001 Feb 16;15(3):335–339. PubMed PMID: 11273213; eng.
   PubMed Web of Science ®Google Scholar
• Jeena PM, Coovadia HM, Chrystal V. Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants. Ann trop paediatrics. 1996 Dec;16(4):361–368. PubMed PMID: 8985536; eng.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cutland C, Ismail K, et al. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia. Clin Infect Dis. 2002 Nov 1;35(9):1120–1126. PubMed PMID: 12384847; eng.
   PubMed Web of Science ®Google Scholar
• McNally LM, Jeena PM, Lalloo U, et al. Probable mother to infant transmission of Pneumocystis jiroveci from an HIV-infected woman to her HIV-uninfected infant. Aids. 2005 Sep 23;19(14):1548–1549. PubMed PMID: 16135912; eng.
   PubMed Web of Science ®Google Scholar
• Morrow BM, Hsaio NY, Zampoli M, et al. Pneumocystis pneumonia in South African children with and without human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Pediatr Infect Dis J. 2010 Jun;29(6):535–539. PubMed PMID: 20072079.
   PubMed Web of Science ®Google Scholar
• Slogrove AL, Cotton MF, Esser MM. Severe infections in HIV-exposed uninfected infants: clinical evidence of immunodeficiency. J Trop Pediatr. 2010 Apr;56(2):75–81. . PubMed PMID: 19602487.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. The use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children. Supplementary section to the 2013 WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, Chapter 8 - Prevention, screening and management of common coinfections. Geneva, Switzerland: World Health Organisation; 2014. p. 28–34.
   Google Scholar
• Nesheim SR, Kapogiannis BG, Soe MM, et al. Trends in opportunistic infections in the pre and post highly active antiretroviral therapy eras among HIV-infected children in the perinatal AIDS collaborative transmission study, 1986 2004. Pediatrics. 2007;120(1):100–109.
   PubMed Web of Science ®Google Scholar
• Nunes MC, Kuschner Z, Rabede Z, et al. Clinical epidemiology of bocavirus, rhinovirus, two polyomaviruses and four coronaviruses in HIV-infected and HIV-uninfected South African children. PLoS One. 2014;9(2):e86448. PubMed PMID: 24498274; PubMed Central PMCID: PMCPMC3911925.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Schoub B, Simmank K, et al. Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. J Pediatr. 2000 Jul;137(1):78–84. PubMed PMID: 10891826.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Ramasamy N, Bessellar TG, et al. Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection. Pediatr Infect Dis J. 2002 Apr;21(4):291–297. PubMed PMID: 12075759; eng.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Ramasamy N, Petersen K, et al. Severe lower respiratory tract infections associated with human parainfluenza viruses 1-3 in children infected and noninfected with HIV type 1. Eur J Clin Microbiol Infect Dis. 2002 Jul;21(7):499–505. PubMed PMID: 12172740; eng.
   PubMed Web of Science ®Google Scholar
• Moore DP, Dagan R, Madhi SA. Respiratory viral and pneumococcal coinfection of the respiratory tract: implications of pneumococcal vaccination. Expert Rev Respir Med. 2012 Aug;6(4):451–465. . PubMed PMID: 22971069; eng.
   PubMed Web of Science ®Google Scholar
• Cohen C, Moyes J, Tempia S, et al. Epidemiology of acute lower respiratory tract infection in HIV-exposed uninfected infants. Pediatrics. 2016 Apr;137(4). PubMed PMID: 27025960; eng. DOI:10.1542/peds.2015-3272.
   Web of Science ®Google Scholar
• McMorrow ML, Tempia S, Walaza S, et al. The role of HIV in influenza- and respiratory syncytial virus-associated hospitalizations in South African children, 2011–2016. Clin Infect Dis. 2018 Jun 29. PubMed PMID: 29961814; eng. doi:10.1093/cid/ciy532.
   Web of Science ®Google Scholar
• Hsiao NY, Zampoli M, Morrow B, et al. Cytomegalovirus viraemia in HIV exposed and infected infants: prevalence and clinical utility for diagnosing CMV pneumonia. J Clin Virol. 2013 Sep;58(1):74–78. PubMed PMID: 23727304.
   PubMed Web of Science ®Google Scholar
• Jeena PM, Govender K, Parboosing R, et al. The significance of cytomegalovirus in children with pneumonia admitted for mechanical ventilation. Int J Tuberculosis Lung Dis. 2017 Dec 1;21(12):1230–1236. PubMed PMID: 29297442; eng.
   Web of Science ®Google Scholar
• Tramper-Stranders GA. Childhood community-acquired pneumonia: A review of etiology- and antimicrobial treatment studies. Paediatr Respir Rev. 2018 Mar;26:41–48. PubMed PMID: 28844414.
   PubMed Web of Science ®Google Scholar
• Klugman KP, Rodgers GL. PERCH in perspective: what can it teach us about pneumonia etiology in children? Clin Infect Dis. 2017 Jun 15;64(suppl_3):S185–s187. . PubMed PMID: 28575353; PubMed Central PMCID: PMCPMC5447840. eng.
   PubMedGoogle Scholar
• Shann F, Hart K, Thomas D. Acute lower respiratory tract infections in children: possible criteria for selection of patients for antibiotic therapy and hospital admission. Bull World Health Organ. 1984;62(5):749–753. PubMed PMID: 6334573; PubMed Central PMCID: PMCPMC2536213. eng.
   PubMed Web of Science ®Google Scholar
• Ghafoor A, Nomani NK, Ishaq Z, et al. Diagnoses of acute lower respiratory tract infections in children in Rawalpindi and Islamabad, Pakistan. Rev Infect Dis. 1990 Nov–Dec;12(Suppl 8):S907–14. PubMed PMID: 2270413; eng.
   PubMedGoogle Scholar
• Barker J, Gratten M, Riley I, et al. Pneumonia in children in the Eastern Highlands of Papua New Guinea: a bacteriologic study of patients selected by standard clinical criteria. J Infect Dis. 1989 Feb;159(2):348–352. PubMed PMID: 2783717; eng.
   PubMed Web of Science ®Google Scholar
• Tupasi TE, Lucero MG, Magdangal DM, et al. Etiology of acute lower respiratory tract infection in children from Alabang, Metro Manila. Rev Infect Dis. 1990 Nov–Dec;12(Suppl 8):S929–39. PubMed PMID: 2270415; eng.
   PubMedGoogle Scholar
• Berman S. Epidemiology of acute respiratory infections in children of developing countries. Rev Infect Dis. 1991 May–Jun;13(Suppl 6):S454–62. PubMed PMID: 1862276; eng.
   PubMedGoogle Scholar
• World Health Organisation. Programme of acute respiratory infections. Acute respiratory infection: case management in small hospitals in developing countries, a manual for doctors and other senior health workers. Geneva: WHO; 1990.
   Google Scholar
• Sazawal S, Black RE. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis. 2003 Sep;3(9):547–556. PubMed PMID: 12954560; eng.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Dept. of Child and Adolescent Health and Development‎. Technical updates of the guidelines on the Integrated Management of Childhood Illness (‎IMCI)‎: evidence and recommendations for further adaptations. Geneva: WHO; 2005.
   Google Scholar
• World Health Organisation. Pocket book of hospital care for children: guidelines for the management of common illnesses with limited resources. Geneva: World Health Organisation; 2005.
   Google Scholar
• Grant GB, Campbell H, Dowell SF, et al. Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis. 2009 Mar;9(3):185–196. PubMed PMID: 19246022; eng.
   PubMed Web of Science ®Google Scholar
• Enarson PM, Gie RP, Enarson DA, et al. Impact of HIV on standard case management for severe pneumonia in children. Expert Rev Respir Med. 2010 Apr;4(2):211–220. PubMed PMID: 20406087; eng.
   PubMedGoogle Scholar
• World Health Organisation. Guidance for national tuberculosis programmes on the management of tuberculosis in children. 2nd ed. Geneva, Switzerland: World Health Organisation; 2014.
   Google Scholar
• Schaaf HS, Geldenduys A, Gie RP, et al. Culture-positive tuberculosis in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J. 1998 Jul;17(7):599–604. PubMed PMID: 9686725; eng.
   PubMed Web of Science ®Google Scholar
• Schaaf HS, Krook S, Hollemans DW, et al. Recurrent culture-confirmed tuberculosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2005;24(8):685–691.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. WHO treatment guidelines for drug-resistant tuberculosis. Geneva, Switzerland: World Health Organisation; 2016.
   Google Scholar
• Chen J, Raymond K. Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor. Ann Clin Microbiol Antimicrob. 2006 Feb 15;5:3.
   PubMedGoogle Scholar
• World Health Organisation. Consolidated guidelines on general HIV care and the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva, Switzerland: World Health Organisation; 2013.
   Google Scholar
• Ren Y, Nuttall JJ, Egbers C, et al. Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):566–569. PubMed PMID: 18197120; eng.
   PubMed Web of Science ®Google Scholar
• Rabie H, Denti P, Lee J, et al. Lopinavir ritonavir (1:1 ratio) in the presence of rifampicin is not inferior to lopinavir ritonavir (4:1 ratio) in the absence of rifampicin in human immune deficiency virus (HIV) children. Interim analysis of an open label sequential non-randomized pharmacokinetics study. LB1-Oral presentation. 7th International Workshop on HIV Pediatrics; 2015 Jul 17–18; Vancouver, Canada.
   Google Scholar
• McIlleron H, Ren Y, Nuttall J, et al. Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis. Antivir Ther. 2011;16(3):417–421. PubMed PMID: 21555825; eng.
   PubMed Web of Science ®Google Scholar
• Moultrie H, McIlleron H, Sawry S, et al. Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir. J Antimicrob Chemother. 2015 Feb;70(2):543–549. PubMed PMID: 25281400; PubMed Central PMCID: PMCPMC4291235.
   PubMed Web of Science ®Google Scholar
• Ren Y, Nuttall JJ, Eley BS, et al. Effect of rifampicin on efavirenz pharmacokinetics in HIV-infected children with tuberculosis. J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):439–443. PubMed PMID: 19223781; eng.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. HIV Treatment. Transition to new antiretrovirals in HIV programmes. Geneva, Switzerland: World Health Organisation; 2017.
   Google Scholar
• World Health Organisation. Policy Brief. Update on antiretroviral regimens for treating and preventing HIV infection and update on early infant diagnosis of HIV. HIV treatment - interim guidance. Geneva, Switzerland: World Health Organisation; 2018.
   Google Scholar
• Krogstad P, Samson P, Meyers T, et al. P1101: phase 1/2 Study of raltegravir-containing regimen in HIV an TB co-treated children aged 6-<12 years. 10th International Workshop on HIV Pediatrics, Amsterdam, Netherlands; 2018.
   Google Scholar
• Dooley KE, Sayre P, Borland J, et al. Safety, tolerability, and pharmacokinetics of the HIV integrase inhibitor dolutegravir given twice daily with rifampin or once daily with rifabutin: results of a phase 1 study among healthy subjects. J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):21–27. PubMed PMID: 23075918; eng.
   PubMed Web of Science ®Google Scholar
• Le M, Cournil A, Kouanfack C, et al. Pharmacokinetic and virological efficacy of dolutegravir (50 mg BID) containing regimen in association with rifampin in HIV-infected patients using dried blood spot: ANRS-12313 NAMSAL substudy in Cameroon. 19th International Workshop on Clinical Pharmacology of Antiviral Therapy; 2018 May; Baltimore.
   Google Scholar
• Malosh RE, Martin ET, Heikkinen T, et al. Efficacy and safety of oseltamivir in children: systematic review and individual patient data meta-analysis of randomized controlled trials. Clin Infect Dis. 2018;66(10):1492–1500.
   PubMed Web of Science ®Google Scholar
• National Institute for Communicable Diseases (NICD) SA. Influenza. NICD recommendations for the diagnosis, prevention, management and public health response. Johannesburg, South Africa: National Institute for Communicable Diseases; 2018.
   Google Scholar
• Zar HJ, Langdon G, Apolles P, et al. Oral trimethoprim-sulphamethoxazole levels in stable HIV-infected children. S Afr Med J. 2006 Jul;96(7):627–629. PubMed PMID: 16909188; eng.
   PubMed Web of Science ®Google Scholar
• Du Toit G, Reynolds L, Eley B. Induction of tolerance after a serious trimethoprim-sulphamethoxazole reaction in an HIV-infected child. S Afr Med J. 2003 May;93(5):358–359. PubMed PMID: 12830598; eng.
   PubMed Web of Science ®Google Scholar
• Zar HJ, Alvarez-Martinez MJ, Harrison A, et al. Prevalence of dihydropteroate synthase mutants in HIV-infected South African children with Pneumocystis jiroveci pneumonia. Clin Infect Dis. 2004 Oct 1;39(7):1047–1051. PubMed PMID: 15472859; eng.
   PubMed Web of Science ®Google Scholar
• Huang YS, Yang JJ, Lee NY, et al. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review. Expert Rev Anti Infect Ther. 2017;15(9):873–892.
   PubMed Web of Science ®Google Scholar
• Bye MR, Cairns-Bazarian AM, Ewig JM. Markedly reduced mortality associated with corticosteroid therapy of Pneumocystis carinii pneumonia in children with acquired immunodeficiency syndrome. Arch Pediatr Adolesc Med. 1994 Jun;148(6):638–641. PubMed PMID: 8193693; eng.
   PubMedGoogle Scholar
• Sleasman JW, Hemenway C, Klein AS, et al. Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia. Am J Dis Children (1960). 1993 Jan;147(1):30–34. PubMed PMID: 8093422; eng.
   PubMedGoogle Scholar
• Terblanche AJ, Green RJ, Rheeder P, et al. Adjunctive corticosteroid treatment of clinical Pneumocystis jiroveci pneumonia in infants less than 18 months of age–a randomised controlled trial. S Afr Med J. 2008 Apr;98(4):287–290. PubMed PMID: 18637638; eng.
   PubMed Web of Science ®Google Scholar
• Newberry L, O’Hare B, Kennedy N, et al. Early use of corticosteroids in infants with a clinical diagnosis of Pneumocystis jiroveci pneumonia in Malawi: a double-blind, randomised clinical trial. Paediatr Int Child Health. 2017 May;37(2):121–128. PubMed PMID: 28145162; eng.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva, Switzerland: World Health Organisation; 2017.
   Google Scholar
• Hakim J, Musiime V, Szubert AJ, et al. Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa. N Engl J Med. 2017 Jul 20;377(3):233–245. PubMed PMID: 28723333; PubMed Central PMCID: PMCPMC5603269. eng.
   PubMed Web of Science ®Google Scholar
• Keenan JD, Bailey RL, West SK, et al. Azithromycin to reduce childhood mortality in Sub-Saharan Africa. N Engl J Med. 2018 Apr 26;378(17):1583–1592. PubMed PMID: 29694816; PubMed Central PMCID: PMCPMC5849140. eng.
   PubMed Web of Science ®Google Scholar